Skip to main content

A History and Analysis of Drug Labeling Policy for Pregnant and Lactating Women and Women's Involvement in Clinical Drug Research from 1970 to 2014

Abstract The inherent risk in testing drugs has been hotly debated since the government first started regulating the drug industry in the early 1900s. Who can assume the risks associated with trying new pharmaceuticals is unclear when looked at through society's lens. In the mid twentieth century, the US Food and Drug Administration (FDA) published several guidance documents encouraging researchers to exclude women from early clinical drug research. The motivation to publish those documents and the subsequent guidance documents in which the FDA and other regulatory offices established their standpoints on women in drug research may have been connected to current events at the time. The problem of whether women should be involved in drug research... (more)
Created Date 2018-05
Contributor Meek, Caroline Jane (Author) / Maienschein, Jane (Thesis Director) / Brian, Jennifer (Committee Member) / School of Life Sciences / Sanford School of Social and Family Dynamics / Barrett, The Honors College
Subject Health Policy / Drugs / Research / Women / Pregnancy
Series Academic Year 2017-2018
Type Text
Extent 66 pages
Language English
Reuse Permissions All Rights Reserved
Collaborating Institutions Barrett, the Honors College
Additional Formats MODS / OAI Dublin Core / RIS

348.9 KB application/pdf
  • Download restricted to ASU - Sign In
Download Count: 10